Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 5, 2011
Patent Application Number
12210802
Date Filed
September 15, 2008
Patent Citations Received
Patent Primary Examiner
Patent abstract
Compounds that reduce serum retinol levels are used to treat ophthalmic conditions associated with the overproduction of waste products that accumulate during the course of the visual cycle. We describe methods, compounds, and compositions to treat, for example, the macular degenerations and dystrophies or to alleviate symptoms associated with such ophthalmic conditions.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.